Toshinobu Kazui

Interests

Research

Assess cardiac function (left and right ventricle also left and right atrial function) under atrial fibrillation, pre and post LVAD implantApplying medical imaging technologies (echo, CT scan) to cardiac surgical treatment (LVAD pump thrombosis and surgical technique, cardiac function after mitral valve repair)Clinical outcome analysisDeveloping medical equipment and devicesApplication of new technologies to surgical treatment

Teaching

Teaching surgical skills,Surgical judgement during surgery,Current topic of surgical management of patients

Courses

Scholarly Contributions

Chapters

• Kazui, T., & Itoh, A. (2014). Cannulation strategy for VA ECMO. In Emergency and Intensive Care Medicine. Japan.
• Shanmugasundaram, M., & Kazui, T. (2022). Elderly and Heart Disease. In Cardiovascular Medicine and Surgery(pp Chapter 20). Philadelphia, PA: Wolters Klewer.
• Kazui, T., Pilikian, T., Lagrand, D., Smith, R., Yacoub, M., & Khalpey, Z. (2015). The Translational Pathway for Mechanical Circulatory Support. In Mechanical Circulatory Support. International Society for Cardiovascular Translational Research, Part II, II.9, 2015.
• Kazui, T., & Itoh, A. (2014). Cannulation strategy for VA ECMO. In Emergency and Intensive Care Medicine. December 2014: Emergency and Intensive Care Medicine.

Journals/Publications

• Kazui, T. (2024). Survival trends in heart transplant patients supported on ECMO and IABP: A 10-year UNOS database analysis. IJC Heart & Vasculature, 54. doi:10.1016/j.ijcha.2024.101486
• Acharya, D., Kazui, T., Al Rameni, D., Acharya, T., Betterton, E., Juneman, E., Loyaga-Rendon, R., Lotun, K., Shetty, R., & Chatterjee, A. (2023). Aortic valve disorders and left ventricular assist devices. Frontiers in cardiovascular medicine, 10, 1098348.
  More info

  Aortic valve disorders are important considerations in advanced heart failure patients being evaluated for left ventricular assist devices (LVAD) and those on LVAD support. Aortic insufficiency (AI) can be present prior to LVAD implantation or develop during LVAD support. It is usually a progressive disorder and can lead to impaired LVAD effectiveness and heart failure symptoms. Severe AI is associated with worsening hemodynamics, increased hospitalizations, and decreased survival in LVAD patients. Diagnosis is made with echocardiographic, device assessment, and/or catheterization studies. Standard echocardiographic criteria for AI are insufficient for accurate diagnosis of AI severity. Management of pre-existing AI includes aortic repair or replacement at the time of LVAD implant. Management of AI on LVAD support is challenging with increased risks of repeat surgical intervention, and percutaneous techniques including transcatheter aortic valve replacement are assuming greater importance. In this manuscript, we provide a comprehensive approach to contemporary diagnosis and management of aortic valve disorders in the setting of LVAD therapy.
• Acharya, D., Manandhar-Shrestha, N., Leacche, M., Rajapreyar, I., William, P., Kazui, T., Hooker, R., Tonna, J., Jovinge, S., & Loyaga-Rendon, R. (2023). Extracorporeal membrane oxygenation as a bridge to advanced heart failure therapies. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 42(8), 1059-1071.
  More info

  Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a key support modality for cardiogenic shock. The 2018 United Network for Organ Sharing (UNOS) heart transplant allocation algorithm prioritizes VA-ECMO patients.
• Chatterjee, A., Kazui, T., & Acharya, D. (2023). Growing prevalence of aortic stenosis - Question of age or better recognition?. International journal of cardiology, 388, 131155.
• Kazui, T., Hsu, C. H., Hamidi, M., Acharya, D., Shanmugasundaram, M., Lee, K., Chatterjee, A., & Bull, D. (2022). Five-meter walk test before transcatheter aortic valve replacement and 1-year noncardiac mortality. JTCVS open, 12, 103-117.
  More info

  The purpose of this study is to assess whether the 5-m walk test is associated with 1-year mortality after transcatheter aortic valve replacement.
• Kazui, T., Hsu, C. H., Lick, S. D., Hypes, C. D., Natt, B., Malo, J., Mosier, J. M., & Bull, D. A. (2022). Outcomes of Venovenous Extracorporeal Membrane Oxygenation in Viral Acute Respiratory Distress Syndrome. ASAIO journal (American Society for Artificial Internal Organs : 1992), 68(11), 1399-1406.
  More info

  Our study assessed the relationship between the duration of venovenous extracorporeal membrane oxygenation (V-V ECMO) and patient outcomes. We studied patients undergoing V-V ECMO support for acute respiratory distress syndrome (ARDS) between 2009 and 2017 who were reported to the Extracorporeal Life Support Organization registry. We evaluated survival, major bleeding, renal failure, pulmonary complications, mechanical complications, neurologic complications, infection, and duration of V-V ECMO support. Multivariable regression modeling assessed risk factors for adverse events. Of the 4,636 patients studied, the mean support duration was 12.2 ± 13.7 days. There was a progressive increase in survival after the initiation of V-VECMO, peaking at a survival rate of 73% at 10 days of support. However, a single-day increase in V-V ECMO duration was associated with increased bleeding events (odds ratio [OR] 1.038; 95% confidence interval [CI]: 1.029-1.047; p < 0.0001), renal failure (OR 1.018; 95% CI: 1.010-1.027; p < 0.0001), mechanical complications (OR 1.065; 95% CI: 1.053-1.076; p < 0.0001), pulmonary complications (OR 1.04; 95% CI: 1.03-1.05; p < 0.0001), and infection (OR 1.04; 95% CI: 1.03-1.05; p < 0.0001). V-V ECMO progressively increases survival for ARDS over the first 10 days of support. Thereafter, rising complications associated with prolonged durations of support result in a progressive decline in survival.
• Kazui, T., Hsu, C., Hamidi, M., Acharya, D., Shanmugasundaram, M., Lee, K., Chatterjee, A., & Bull, D. (2022). Five-meter walk test before transcatheter aortic valve replacement and 1-year noncardiac mortality.. Journal of Thoracic and Cardiovascular Surgery OPEN..
• Kazui, T., Hsu, C., Malo, J., Mosier, J. M., Natt, B., Hypes, C., Lick, S. D., & Bull, D. A. (2021). Outcomes of venovenous extracorporeal membrane oxygenation support in acute respiratory distress syndrome. Annals of Thoracic Surgery.
• Kazui, T., Kazui, T., Hsu, C., Hsu, C., Hamidi, M., Hamidi, M., Acharya, D., Acharya, D., Shanmugasundaram, M., Shanmugasundaram, M., Lee, K., Lee, K., Chatterjee, A., Chatterjee, A., Bull, D. A., & Bull, D. A. (2021). Pre-transcatheter aortic valve replacement 5-meter-walk test score and 1-year noncardiac mortality. Journal of Thoracic and Cardiovascular Surgery.
• Kazui, T., Nielsen, V. G., Audie, S. D., Venkataramani, R. M., Bryant, J. T., Swenson, K., & Ford, P. M. (2022). A Case Report of Severe Factor XI Deficiency during Cardiac Surgery: Less Can Be More. Journal of cardiovascular development and disease, 9(4).
  More info

  Severe congenital Factor XI (FXI) deficiency (
• Kazui, T., Nielsen, V., Audie, S., Venkataramani, R., Bryant, J., Swenson, K., & Ford, P. (2022). A case report of severe factor Xl deficiency during cardiac surgery: less can be more.. Journal of Cardiovascular Development and Disease., 9((4)), 118.
• Ferng, A., Lick, S. D., Connell, A., Desai, A., Pilikian, T., Kazui, T., Nunez, M., Runyan, R. B., Ferng, A., Johnson, K., Connell, A., Braunhut, B., Pilikian, T., Lick, S. D., Nunez, M., Desai, A., Johnson, K., Kazui, T., Braunhut, B., , Runyan, R. B., et al. (2017). Cardiac regeneration in the human left ventricle following Cormatrix implant. Journal of Cardiothoracic Surgery.
• Iwanski, J., Kazmouz, S. G., Li, S., Stansfield, B., Salem, T. T., Perez-Miller, S., Kazui, T., Jena, L., Uhrlaub, J. L., Lick, S., Nikolich-Žugich, J., Konhilas, J. P., Gregorio, C. C., Khanna, M., Campos, S. K., & Churko, J. M. (2021). Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells. Stem cell reports, 16(10), 2459-2472.
  More info

  The pathogenicity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been attributed to its ability to enter through the membrane-bound angiotensin-converting enzyme 2 (ACE2) receptor. Therefore, it has been heavily speculated that angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) therapy may modulate SARS-CoV-2 infection. In this study, exposure of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and human endothelial cells (hECs) to SARS-CoV-2 identified significant differences in protein coding genes involved in immunity, viral response, and cardiomyocyte/endothelial structure. Specifically, transcriptome changes were identified in the tumor necrosis factor (TNF), interferon α/β, and mitogen-activated protein kinase (MAPK) (hPSC-CMs) as well as nuclear factor kappa-B (NF-κB) (hECs) signaling pathways. However, pre-treatment of hPSC-CMs or hECs with two widely prescribed antihypertensive medications, losartan and lisinopril, did not affect the susceptibility of either cell type to SARS-CoV-2 infection. These findings demonstrate the toxic effects of SARS-CoV-2 in hPSC-CMs/hECs and, taken together with newly emerging multicenter trials, suggest that antihypertensive drug treatment alone does not alter SARS-CoV-2 infection.
• Kazui, T. (2021). Duration of venovenous extracorporeal membrane oxygenation support and adverse outcomes in acute respiratory syndrome. ASAIO.
• Kazui, T., Hsu, C., Lick, S. D., & Bull, D. A. (2020). Short term risk of bilateral internal mammary artery grafting in diabetic patients. Seminars in Thoracic and Cardiovascular Surgery.
• Kazui, T., Lick, S. D., Hsu, C. H., & Bull, D. A. (2021). Short-Term Risk of Bilateral Internal Mammary Artery Grafting in Diabetic Patients. Seminars in thoracic and cardiovascular surgery, 33(2), 382-392.
  More info

  This study compares the morbidity and mortality at 30 days following the use of bilateral internal mammary arteries (BIMA) vs a single internal mammary artery (SIMA) at the time of coronary artery bypass grafting (CABG) in patients with a preoperative HbA1c. Patients undergoing CABG from January 2008 to December 2016 reported to the Society of Thoracic Surgeons database were retrospectively reviewed. The patients were divided into 2 groups: use of BIMA or use of SIMA and propensity matched. To assess the effect of preoperative HbA1c, both groups were further divided into 5 subgroups: patients without diabetes mellitus (DM), or patients with DM and a preoperative HbA1c level in one of four groups (< 7%, 7-9%, 9-11%, or >11%). The postoperative outcomes in both the BIMA and SIMA groups were compared. There were 700,504 and 28,115 patients with measured preoperative HbA1c levels in the SIMA and BIMA groups, respectively. Propensity score matching identified 23,635 comparable patients in each group for analysis. There was no difference in postoperative mortality between the BIMA and SIMA groups (1.3% vs 1.2%). The incidences of sternal wound infection (SWI) in patients undergoing placement of BIMA vs SIMA were: 0.8% vs 0.4% with no DM (P < 0.0001), 1.9% vs 1.0% with HbA1c < 7% (P < 0.001), 2.4% vs 1.2% with HbA1c 7-9% (P < 0.001), 2.8% vs 1.4% with HbA1c 9-11% (P = 0.02), 4.1% vs 1.5% with HbA1c > 11% (P = 0.01). Based on the incidence of SWI, BIMA is a reasonable approach with an HbA1c
• Loyaga-Rendon, R. Y., Kazui, T., & Acharya, D. (2021). Antiplatelet and anticoagulation strategies for left ventricular assist devices. Annals of translational medicine, 9(6), 521.
  More info

  Left ventricular assist devices (LVAD) have revolutionized the management of advanced heart failure. However, complications rates remain high, among which hemorrhagic and thrombotic complications are the most important. Antiplatelet and anticoagulation strategies form a cornerstone of LVAD management and may directly affect LVAD complications. Concurrently, LVAD complications influence anticoagulation and anticoagulation management. A thorough understanding of device, patient, and management, including anticoagulation and antiplatelet therapies, are important in optimizing LVAD outcomes. This article provides a comprehensive state of the art review of issues related to antiplatelet and anticoagulation management in LVADs. We start with a historical overview, the epidemiology and pathophysiology of bleeding and thrombotic complications in LVADs. We then discuss platelet and anticoagulation biology followed by considerations prior to, during, and after LVAD implantation. This is followed by discussion of anticoagulation and the management of thrombotic and hemorrhagic complications. Specific problems, including management of heparin-induced thrombocytopenia, anticoagulant reversal, novel oral anticoagulants, artificial heart valves, and noncardiac surgeries are covered in detail.
• Nielsen, V. G., Kazui, T., Horn, E. A., & Dotson, V. E. (2021). Thrombocytosis and neutrophilia associated with oxygenator failure and protamine reaction after cardiopulmonary bypass: a case report and literature review. Journal of thrombosis and thrombolysis, 52(4), 1220-1226.
  More info

  Thrombocytosis has been feared as a source of thrombotic complications during the conduct of cardiopulmonary bypass (CPB) for patients undergoing cardiac procedures. We present a patient urgently requiring repair/replacement of three heart valves that had preexisting myelofibrosis with thrombocytosis (platelet count of 800,000 per µl) and neutrophilia (40,000 per µl). Despite achieving an activated clotting time > 500 s with heparin and antithrombin concentrate administration prior to CPB, the pump oxygenator and reservoir demonstrated significant clot just prior to restoration of the patient's circulation. The patient subsequently suffered a severe protamine reaction that was successfully managed. A review of the literature of similar patients and the relevant cellular and biochemical mechanisms in this setting are presented, with potential therapeutic approaches to prevent such complications noted.
• Ajmal, M., Reddy, S., Shetty, R., Kazui, T., & Lotun, K. (2020). Degenerated TAVR Within Degenerated Surgical Bioprosthetic Valve Treated With Second TAVR. JACC. Case reports, 2(8), 1097-1098.
  More info

  Transcatheter aortic valve replacement within a degenerated surgical bioprosthetic aortic valve is increasing in frequency. We present a rare case of a patient requiring a second TAVR placed within a previous placed degenerated transcatheter aortic valve, which was implanted in a degenerated surgical bioprosthetic aortic valve. ().
• Dhakal, B. P., Skinner, K. A., Kumar, K., Lotun, K., Shetty, R., Kazui, T., Lee, K., & Indik, J. H. (2020). Arrhythmias in Relation to Mortality After Transcatheter Aortic Valve Replacement. The American journal of medicine, 133(11), 1336-1342.e1.
  More info

  The purpose of this study was to identify predictors of mortality and potentially modifiable factors related to arrhythmias in patients that undergo transcatheter aortic valve replacement (TAVR). Patients that undergo TAVR are at risk for complete heart block requiring pacemaker implant. Additionally, other arrhythmias, specifically atrial fibrillation (AF), are common in this population. It is unclear how arrhythmias and their management contribute to mortality risk.
• Kazui, T., Acharya, D., & Loyaga-Rendon, R. Y. (2020). Antiplatelet and anticoagulation strategies for left ventricular assist devices. Annals of Translational Medicine, 1-17.
• Kazui, T., Ajmal, M., Reddy, S., Shetty, R., & Lotun, K. (2020). Valve-in-valve-in-valve: Degenerated transcatheter heart valve within degenerated surgical bioprosthetic aortic valve treated with second transcatheter heart valve. Reports, 7.
• Basken, R., Cosgrove, R., Malo, J., Romero, A., Patanwala, A., Finger, J., Kazui, T., Khalpey, Z., & Mosier, J. (2019). Predictors of Oxygenator Exchange in Patients Receiving Extracorporeal Membrane Oxygenation. The journal of extra-corporeal technology, 51(2), 61-66.
  More info

  Thrombosis within the membrane oxygenator (MO) during extracorporeal membrane oxygenation (ECMO) can lead to sudden oxygenator dysfunction with deleterious effects to the patient. The purpose of this study was to identify predictors of circuit exchange during ECMO. This is a single-center, retrospective study of all patients who received ECMO at our institution from January 2010 to December 2015. Changes in potential markers were compared on Day 3 vs. Day 0 before MO exchange. Of the 150 patients who received ECMO, there were 58 MO exchanges in 35 patients. Mean ECMO duration was 21.1 (±12.7) days. D-dimer (DD) (μg/mL) (mean difference -2.6; 95% confidence interval [CI]: -4.2 to -1.1; = .001) increased significantly in the 3 days leading up to MO exchange, whereas fibrinogen (mg/dL) (mean difference 90.7; 95% CI: 41.8-139.6; = .001), platelet (PLT) count (1,000/μL) (mean difference 23.3; 95% CI: 10.2-36.4; = .001), and heparin dose (units/h) (mean difference 261.7; 95% CI: 46.3-477.1; = .02) decreased. Increasing DD or decreasing fibrinogen, PLT count, or heparin dose may indicate an impending need for MO exchange in patients receiving ECMO. Early identification of these changes may help prevent sudden MO dysfunction.
• Cosgrove, R. H., Basken, R. L., Smith, R. G., Hsu, C. H., Kazui, T., Martinez, B. K., Burt, R. W., Crawford, E. S., Lick, S. D., & Khalpey, Z. (2018). Anticoagulant Bridge Comparison in Mechanical Circulatory Support Patients. ASAIO journal (American Society for Artificial Internal Organs : 1992).
  More info

  Maintaining mechanical circulatory support (MCS) device patients in a specified therapeutic range for anticoagulation remains challenging. Subtherapeutic international normalized ratios (INRs) occur frequently while on warfarin therapy. An effective anticoagulant bridge strategy may improve the care of these patients. This retrospective review of MCS patients with subtherapeutic INRs compared an intravenous unfractionated heparin (UFH) strategy with a subcutaneous enoxaparin or fondaparinux strategy. Native thromboelastography (n-TEG) was used to evaluate anticoagulant effect with coagulation index (CI) as the primary outcome measure. Enoxaparin 0.5 mg/kg SC q12hrs or fondaparinux 2.5-5 mg SC daily were compared with an initial UFH rate of 5 units/kg/hr and titrated to stated n-TEG goal range. The anticoagulant groups UFH, enoxaparin, and fondaparinux were found to be statistically similar with regard to frequency in n-TEG goal range, above range (hypercoagulability), or below range (hypocoagulability). Clinical outcomes were similar among groups with three gastrointestinal bleeds in UFH, one in enoxaparin, and one in fondaparinux groups. Device thrombosis occurred in one UFH patient, while UFH and fondaparinux groups had one ischemic cerebrovascular accident event each. These strategies provided comparable n-TEG results and clinical outcomes when compared with intravenous UFH. Low-dose enoxaparin or fondaparinux may provide an alternative anticoagulant bridging option in MCS patients presenting with subtherapeutic INR.
• Kazui, T., Lin, T. M., & Lick, S. D. (2018). Coronary Sinus Rupture Repair: Patency Is Important. The Annals of thoracic surgery.
  More info

  We report a case of coronary sinus (CS) injury with a retrograde cardioplegia catheter and repair compromising CS patency. This resulted in acute global cardiac dysfunction shortly after weaning from bypass, which reversed after patch repair with confirmed CS patency. The case shows that acute CS occlusion may not be tolerated in some humans.
• Avery, R., Day, K., Jokerst, C., Kazui, T., Krupinski, E., & Khalpey, Z. (2017). Right ventricular functional analysis utilizing first pass radionuclide angiography for pre-operative ventricular assist device planning: a multi-modality comparison. Journal of cardiothoracic surgery, 12(1), 89.
  More info

  Advanced heart failure treated with a left ventricular assist device is associated with a higher risk of right heart failure. Many advanced heart failures patients are treated with an ICD, a relative contraindication to MRI, prior to assist device placement. Given this limitation, left and right ventricular function for patients with an ICD is calculated using radionuclide angiography utilizing planar multigated acquisition (MUGA) and first pass radionuclide angiography (FPRNA), respectively. Given the availability of MRI protocols that can accommodate patients with ICDs, we have correlated the findings of ventricular functional analysis using radionuclide angiography to cardiac MRI, the reference standard for ventricle function calculation, to directly correlate calculated ejection fractions between these modalities, and to also assess agreement between available echocardiographic and hemodynamic parameters of right ventricular function.
• Avery, R., Kazui, T., Krupinski, E. A., & Khalpey, Z. I. (2017). Right ventricular functional analysis utilizing first pass radionuclide angiography for pre-operative ventricular assist device planning: a multi-modality comparison. J Cardiothorac Surg, 10(12), 89.
• Ferng, A., Connell, A., Nunez, M., Johnson, K., Braunhut, B., Lick, S., Desai, A., Kazui, T., Runyan, R., & Khalpey, Z. (2017). Cardiac Regeneration in the Human Left Ventricle After CorMatrix Implantation. The Annals of Thoracic Surgery, 104(3), e239-e241.
  More info

  CorMatrix is an organic extracellular matrix (ECM) derived from porcine small intestine submucosa and is used for pericardial closure and cardiac tissue repair. During explantation of a HeartMate II (Thoratec Corp, Pleasanton, CA) left ventricular assist device (LVAD) because of infection, CorMatrix was used to repair the left ventricular apex and aorta. Three months later, a HeartWare HVAD (HeartWare International, Inc, Framingham, MA) was implanted for recurrent heart failure. Excised apical CorMatrix samples showed cardiac tissue remodeling with viable cardiomyoblasts similar to native myocardium. Excised CorMatrix from the aorta showed organization of collagen and elastin similar to native aortic tissue.
• Kazui, T., Khalpey, Z. I., Konhilas, J. P., Runyan, R. B., Runyan, R. B., Konhilas, J. P., Khalpey, Z. I., & Kazui, T. (2017). A dual therapy of off-pump temporary left ventricular extracorporeal device and amniotic stem cell for cardiogenic shock. J Cardiothorac Surg, 7(12), 80.
• Kazui, T., Tran, P. L., Pilikian, T. R., Marsh, K. M., Runyan, R., Konhilas, J., Smith, R., & Khalpey, Z. I. (2017). A dual therapy of off-pump temporary left ventricular extracorporeal device and amniotic stem cell for cardiogenic shock. Journal of cardiothoracic surgery, 12(1), 80.
  More info

  Temporary mechanical circulatory support device without sternotomy has been highly advocated for severe cardiogenic shock patient but little is known when coupled with amniotic stem cell therapy.
• Khalpey, Z., Rawashdeh, B., Kazui, T., & Lick, S. (2017). Bileaflet Foldoplasty in Barlow’s Disease. The Journal of heart valve disease, 26(3), 355-357.
  More info

  Mitral valve repair is a feasible and preferable option for the treatment of Barlow's disease. Complex valve repair techniques, in contrast, often lead to increased cross-clamp times and low cardiac output syndrome. A simple, fast, and reproducible foldoplasty technique to reduce anterior and posterior mitral leaflet heights may improve coaptation and reduce mitral regurgitation. Accordingly, herein are described minimally invasive, successful trans-septal and robotic approaches for a bileaflet foldoplasty technique in two patients with Barlow's disease.
• Natt, B., Hypes, C., Basekn, R., Malo, J., Kazui, T., & Mosier, J. M. (2017). The use of extracorporeal membrane oxygenation in the bronchoscopic management of critical upper airway obstruction. Journal of Extra Corporeal Technology, 49(1), 54-58.
• Natt, B., Hypes, C., Basken, R., Malo, J., Kazui, T., & Mosier, J. (2017). Suspected Heparin-Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation. The journal of extra-corporeal technology, 49(1), 54-58.
  More info

  Heparin-induced thrombocytopenia (HIT) is an immune reaction usually secondary to unfractionated heparin. Anticoagulation management is critical in patients while on extracorporeal membrane oxygenation (ECMO) to prevent thromboembolism and for the optimal functioning of the circuit. We identified five patients with respiratory failure at our hospital managed with ECMO in the last 2 years that were treated for HIT. A brief clinical course and their management are discussed. We also briefly review the literature for best evidence for management of such patients.
• Natt, B., Hypes, C., Basken, R., Malo, J., Kazui, T., & Mosier, J. M. (2017). Suspected Heparin Induced Thrombocytopenia in patients receiving Extracorporeal Membrane Oxygenation: a case series.. Journal of ExtraCorporeal Technology.
• Natt, B., Knepler, J., Kazui, T., & Mosier, J. M. (2017). The Use of Extracorporeal Membrane Oxygenation in the Bronchoscopic Management of Critical Upper Airway Obstruction. Journal of bronchology & interventional pulmonology, 24(1), e12-e14.
• Schipper, D. A., Palsma, R., Marsh, K. M., O'Hare, C., Dicken, D. S., Lick, S., Kazui, T., Johnson, K., Smolenski, R. T., Duncker, D. J., & Khalpey, Z. (2017). Chronic Myocardial Ischemia Leads to Loss of Maximal Oxygen Consumption and Complex I Dysfunction. The Annals of thoracic surgery, 104(4), 1298-1304.
  More info

  Cardiomyocytes rely heavily on mitochondrial energy production through oxidative phosphorylation. Chronic myocardial ischemia may cause mitochondrial dysfunction and affect ATP formation. Metabolic changes due to ischemia alters cardiac bioenergetics and hence myocardial function and overall bioenergetic state. Here, we evaluate differences in functional status of respiratory complexes in mitochondrial isolates extracted from left atrial appendage tissue (LAA) from patients undergoing cardiac surgery, with and without chronic ischemia.
• Watanabe, Y., Schill, M. R., Kazui, T., Melby, S. J., Schuessler, R. B., & Damiano, R. J. (2017). Strategies to Improve the Efficacy of Epicardial Linear Ablation on the Beating Heart. Innovations (Philadelphia, Pa.), 11(6), 414-419.
  More info

  Creating transmural linear lesions on the beating heart is an important component of minimally invasive surgical ablation for atrial fibrillation. Animal studies have shown poor efficacy for surface bipolar radiofrequency ablation (RFA). Clinicians have developed strategies including multiple device applications and vena caval occlusion (VCO) to improve ablation efficacy. These techniques were evaluated in an acute porcine model.
• Iwanski, J., Kazui, T., Le Tran, P., Basken, R., Wong, R. K., & Khalpey, Z. (2016). Novel method using rotational thromboelastography analysis for intraoperative management of device patient with heparin-induced thrombocytopenia. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
  More info

  Heparin-induced thrombocytopenia (HIT) is a prothrombotic disease in response to previous heparin exposure. Direct thrombin inhibitors are suitable candidates for the prophylaxis of thrombosis in patients with HIT. Currently activated clotting time and activated partial thromboplastin time are used to guide dosing and monitor anticoagulation. These assays provide a measure of clot initiation and only account for a small fraction of the coagulation pathway. In this case study we performed rotational thromboelastography (ROTEM) analysis on a patient with HIT implanted with a continuous-flow CentriMag device for left ventricular support. ROTEM evaluation confirmed a decline in activated clotting time values and provided information regarding intrinsic and extrinsic clotting times. Monitoring ROTEM parameters aided in the detection of coagulopathies and the decision to administer platelet or fresh frozen plasma products. Utilizing ROTEM can guide clinical decisions in transfusions, particularly in patients with HIT, where platelet and fibrinogen levels can be safely maintained to prevent thrombosis.
• Iwanski, J., Tran, P. L., Jerman, C., Smith, R., Kazui, T., & Khalpey, Z. (2016). Off-pump left ventricular assist device exchange via re-do left mini-thoracotomy with original outflow graft preservation. Perfusion.
  More info

  Complications associated with long-term left ventricular assist device (LVAD) use may require pump exchange due to device thrombosis or thromboembolism. Minimally invasive off-pump procedures represent an advantageous alternative to standard full sternotomy exchanges and those performed with the use of cardiopulmonary bypass. By mitigating surgical invasion and trauma to the central chest, the potential for post-operative bleeding, transfusions and complications can be reduced. This case report describes the successful off-pump exchange of a HeartWare LVAD via left re-do-thoracotomy with the re-use of the original outflow graft.
• Kazui, T. (2016). A comparison of right ventricular function calculated by first-pass radionuclide angiography and cardiac magnetic resonance for ventricular assist device pre-procedural planning.. Zenodo.
• Kazui, T. (2016). Novel hybrid therapy: Stem cell liquid matrix and negative pressure therapy promote sternal wound healing. EC Microbiology.
• Kazui, T., Itoh, A., & Silvestry, S. C. (2016). Abdominal wall perforation caused by left ventricular assist device driveline insertion: Potential lethal complication. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 35(3), 394-5.
• Kazui, T., Nicole, S., Friedman, M., Kim, S. S., Lick, S., & Khalpey, Z. I. (2016). A modified Park's stitch to correct aortic insufficiency for bioprosthetic valve at time of left ventricular assist device implant: a case report.. Journal of Cardiothoracic Surgery, 11(1), 161.
• Kazui, T., Sydow, N., Friedman, M., Kim, S., Lick, S., & Khalpey, Z. (2016). A modified Park's stitch to correct aortic insufficiency for bioprosthetic valve at time of left ventricular assist device implant: a case report. Journal of cardiothoracic surgery, 11(1), 161.
  More info

  Aortic valve insufficiency (AI) at the time of left ventricular assist device (LVAD) insertion needs to be corrected, however there is little known about how to manage bioprosthetic valvular AI.
• Kazui, T., Tran, P. L., Echeverria, A., Jerman, C. F., Iwanski, J., Kim, S. S., Smith, R. G., & Khalpey, Z. I. (2016). Minimally invasive approach for percutaneous CentriMag right ventricular assist device support using a single PROTEKDuo Cannula. Journal of cardiothoracic surgery, 11(1), 123.
  More info

  Right ventricular failure is a serious complication after left ventricular assist device placement.
• Kazui, T., Zhang, A., Greenberg, J., Itoh, A., Tran, P. L., Keith, A. D., Ewald, G. A., Damiano, R. J., & Silvestry, S. C. (2016). Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function. The Annals of thoracic surgery.
  More info

  This study investigates the impact of left ventricular assist device (LVAD) inflow cannula angulation, pump positional change over time, and the incidence of thrombotic pump dysfunction in a large cohort of HeartMate II (HM2) patients.
• Khalpey, Z., Kazui, T., Ferng, A. S., Connell, A., Tran, P. L., Meyer, M., Rawashdeh, B., Smith, R. G., Sweitzer, N. K., Friedman, M., Lick, S., Slepian, M. J., & Copeland, J. G. (2016). First North American 50 cc Total Artificial Heart Experience: Conversion from a 70 cc Total Artificial Heart. ASAIO journal (American Society for Artificial Internal Organs : 1992), 62(5), e43-5.
  More info

  The 70 cc total artificial heart (TAH) has been utilized as bridge to transplant (BTT) for biventricular failure. However, the utilization of 70 cc TAH has been limited to large patients for the low output from the pulmonary as well as systemic vein compression after chest closure. Therefore, the 50 cc TAH was developed by SynCardia (Tucson, AZ) to accommodate smaller chest cavity. We report the first TAH exchange from a 70 to 50 cc due to a fit difficulty. The patient failed to be closed with a 70 cc TAH, although the patient met the conventional 70 cc TAH fit criteria. We successfully closed the chest with a 50 cc TAH.
• Khalpey, Z., Smith, R., Echeverria, A., le Tran, P., & Kazui, T. (2016). A novel minimally invasive off-pump biventricular assist device insertion technique. The Journal of thoracic and cardiovascular surgery, 151(1), e5-7.
• Lick, S. D., Tran, P. L., Kazui, T., Smith, R. G., & Khalpey, Z. I. (2016). Total Artificial Heart, Augmented by Veno-Venous Extracorporeal Membrane Oxygenation. ASAIO journal (American Society for Artificial Internal Organs : 1992).
  More info

  Shortly after SynCardia Total Artificial Heart (TAH) implant, veno-venous extra-corporeal membrane oxygenation (ECMO) via a 31-French Avalon cannula was used for profound hypoxic lung dysfunction. Immediately after starting ECMO, TAH flow increased by 1.5-2.0 liters/minute, presumably due to augmented TAH filling by the ECMO jet.
• Saint, L. L., Lawrance, C. P., Okada, S., Kazui, T., Robertson, J. O., Schuessler, R. B., & Damiano, R. J. (2016). Performance of a novel bipolar/monopolar radiofrequency ablation device on the beating heart in an acute porcine model. Innovations (Philadelphia, Pa.), 8(4), 276-83.
  More info

  Although the advent of ablation technology has simplified and shortened surgery for atrial fibrillation, only bipolar clamps have reliably been able to create transmural lesions on the beating heart. Currently, there are no devices capable of reproducibly creating the long linear lesions in the right and left atria needed to perform a Cox-Maze procedure. This study evaluated the performance of a novel suction-assisted radiofrequency device that uses both bipolar and monopolar energy to create lesions from an epicardial approach on the beating heart.
• Kazui, T. (2016). Strategies to improve the efficacy of epicardial linear ablation on the beating heart. Innovation.
• Kazui, T., Henn, M. C., Watanabe, Y., Kovács, S. J., Lawrance, C. P., Greenberg, J. W., Moon, M., Schuessler, R. B., & Damiano, R. J. (2015). The impact of 6 weeks of atrial fibrillation on left atrial and ventricular structure and function. The Journal of thoracic and cardiovascular surgery, 150(6), 1602-1608.e1.
  More info

  The impact of prolonged episodes of atrial fibrillation on atrial and ventricular function has been incompletely characterized. The purpose of this study was to investigate the influence of atrial fibrillation on left atrial and ventricular function in a rapid paced porcine model of atrial fibrillation.
• Kazui, T., Henn, M., Watanabe, Y., Kovacs, S., Lawrance, C., Greenberg, J., Moon, M., Schussler, R., & Damiano, R. (2015). The impact of six weeks of atrial fibrillation on left atrial and ventricular structure and function.. J Thorac Cardiovasc Surg.
• Kazui, T., Khalpey, Z., Smith, R., Echeverria, A., & Tran, P. L. (2015). A novel minimally invasive off-pump biventricular assist device insertion technique.. J Thorac Cardiovasc Surg.
• Lick, S. D., Desai, A., Kazui, T., Runyan, R. B., Ferng, A., Connell, A., Pilikian, T., Nunez, M., Johnson, K., Braunhut, B., & Khalpey, Z. I. (2017). Cardiac regeneration in the human left ventricle following Cormatrix implant. Journal of Cardiothoracic Surgery.
• Tran, P. L., Kazui, T., Perovic, V., Mikail, P., Lick, S., Smith, R., Betterton, E. W., Venkat, R., Iwanski, J., Wong, R. K., Slepian, M. J., & Khalpey, Z. (2015). Case Report: Disparate flow in HeartMate II patient with extensive left ventricle repair. Perfusion.
  More info

  This case study reports the operative management of a 63-year-old male patient following implantation of the HeartMate II (HMII) left ventricular assist device (LVAD), with a non-compliant left ventricle (LV) and a reduced right ventricular (RV) end-diastolic volume. Intraoperatively, the patient had a thin, fragile LV wall with laminated clot; a ventricular septal defect was encountered during removal of the clot. Along with an aortic valve repair, the LV and the septum were reconstructed with multiple bovine pericardium patches, thus, moderately reducing the RV and LV stroke volume. A difference in cardiac output via a Swan-Ganz catheter (approximately 1.5 l/min) was observed as opposed to the HMII's estimated flow. The result was later replicated and verified in vitro via the Donovan Mock Circulation System (DMCS), where about 2 l/min lower flow on the HMII system was observed. In conclusion, the HMII flow rate displayed can be inaccurate and should only be used for trending.
• Tran, P. L., Pietropaolo, M., Valerio, L., Brengle, W., Wong, R. K., Kazui, T., Khalpey, Z. I., Redaelli, A., Sheriff, J., Bluestein, D., & Slepian, M. J. (2015). Hemolysate-mediated platelet aggregation: an additional risk mechanism contributing to thrombosis of continuous flow ventricular assist devices. Perfusion.
  More info

  Despite the clinical success and growth in the utilization of continuous flow ventricular assist devices (cfVADs) for the treatment of advanced heart failure, hemolysis and thrombosis remain major limitations. Inadequate and/or ineffective anticoagulation regimens, combined with high pump speed and non-physiological flow patterns, can result in hemolysis which often is accompanied by pump thrombosis. An unexpected increase in cfVADs thrombosis was reported by multiple major VAD implanting centers in 2014, highlighting the association of hemolysis and a rise in lactate dehydrogenase (LDH) presaging thrombotic events. It is well established that thrombotic complications arise from the abnormal shear stresses generated by cfVADs. What remains unknown is the link between cfVAD-associated hemolysis and pump thrombosis. Can hemolysis of red blood cells (RBCs) contribute to platelet aggregation, thereby, facilitating prothrombotic complications in cfVADs? Herein, we examine the effect of RBC-hemolysate and selected major constituents, i.e., lactate dehydrogenase (LDH) and plasma free hemoglobin (pHb) on platelet aggregation, utilizing electrical resistance aggregometry. Our hypothesis is that elements of RBCs, released as a result of shear-mediated hemolysis, will contribute to platelet aggregation. We show that RBC hemolysate and pHb, but not LDH, are direct contributors to platelet aggregation, posing an additional risk mechanism for cfVAD thrombosis.
• Tran, P., Kazui, T., Pervic, V., Mikail, P., Lick, S., Smith, R., Betterton, E., Venkat, R., Iwanski, J., Wong, R., Slepian, M., & Khalpey, Z. (2015). Case Report: Disparate flow in HeartMate II patient with extensive left ventricular repair.. Perfusion.
• Watanabe, Y., Weimar, T., Kazui, T., Lee, U., Schuessler, R. B., & Damiano, R. J. (2014). Epicardial ablation performance of a novel radiofrequency device on the beating heart in pigs. The Annals of thoracic surgery, 97(2), 673-8.
  More info

  Only bipolar clamps create reliable transmural lesions on the beating heart. This study evaluated the performance of a new radiofrequency (RF) device on the beating heart in an acute porcine model.
• Weimar, T., Watanabe, Y., Kazui, T., Lee, U. S., Montecalvo, A., Schuessler, R. B., & Moon, M. R. (2013). Impact of differential right-to-left shunting on systemic perfusion in pulmonary arterial hypertension. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 81(5), 888-95.
  More info

  This study aimed at identifying the ideal right-to-left shunt-fraction to improve cardiac output (CO) and systemic perfusion in pulmonary arterial hypertension (PHT).
• Kazui, T. (2012). Differential impact of interatrial shunting on systemic perfusion in pulmonary hypertension. The Thoracic and Cardiovascular Surgeon, S 01, 60.
• Weimar, T., Watanabe, Y., Kazui, T., Lee, U. S., Moon, M. R., Schuessler, R. B., & Damiano, R. J. (2012). Differential impact of short periods of rapid atrial pacing on left and right atrial mechanical function. American journal of physiology. Heart and circulatory physiology, 302(12), H2583-91.
  More info

  Current techniques to describe atrial function are limited by their load dependency and hence do not accurately reflect intrinsic mechanical properties. To assess the impact of atrial fibrillation on atrial function, combined pressure-volume relationships (PVR) measured by conductance catheters were used to evaluate the right (RA) and left (LA) atrium in 12 isoflurane-anesthetized pigs. Biatrial PVR were recorded over a wide range of volumes during transient caval occlusion at baseline sinus rhythm (SR), after onset of rapid atrial pacing (RAP), after 1 h of RAP, after conversion to SR, and after 1 h of recovery. Cardiac output decreased by 16% (P = 0.008) with onset of RAP. Mean LA and RA pressures increased by 21 and 40% (P < 0.001), respectively, and remained elevated during the entire recovery period. RA reservoir function increased from 51 to 58% and significantly dropped to 43% after resumption of SR (P = 0.017). Immediately after RAP, a right shift of LA end-systolic PVR-intercept for end-systolic volume required to generate an atrial end-systolic pressure of 10 mmHg (24.4 ± 4.9 to 28.1 ± 5.2 ml, P = 0.005) indicated impaired contractility compared with baseline. Active LA emptying fraction dropped from 17.6 ± 7.5 to 11.7 ± 3.7% (P < 0.001), LA stroke volume and ΔP/Δt(max)/P declined by 22% (P = 0.038 and 0.026, respectively), while there was only a trend to impaired RA systolic function. Stiffness quantified by the ratio of pressure to volume at end-diastole was increased immediately after RAP only in the RA (P = 0.020), but end-diastolic PVR shifted rightward in both atria (P = 0.011 LA, P = 0.045 RA). These data suggest that even short periods of RAP have a differential impact on RA and LA function, which was sustained for 1 h after conversion to SR.
• Kazui, T. (2011). Low-Energy Three-Stage Electrotherapy Delivered Through Endocardial Leads Terminates Ventricular Tachycardia With Higher Efficacy Than Anti-Tachycardia Pacing. Circulation, 124(21), A15917.
• Kazui, T. (2011). Low=Energy Three-Stage Electrotherapy Delivered Through Implantable Leads Significantly Reduces the Cardioversion Threshold in a Canine Model of Persistent Atrial Fibrillation. Circulation, 124(21), A16129.
• Kazui, T., Niinuma, H., Tsuboi, J., & Okabayashi, H. (2011). Changes in left ventricular twist after mitral valve repair. The Journal of thoracic and cardiovascular surgery, 141(3), 716-24.
  More info

  We performed echocardiographic tissue tracking to investigate whether mitral valve repair preserves left ventricular function.
• Yamasaki, M., Watanabe, S., Abe, K., Kazui, T., & Kawazoe, K. (2011). A staged total aortic replacement with combined endovascular and open surgery: report of a case. Annals of vascular diseases, 4(4), 340-3.
  More info

  For a 75 year-old man with extensive aortic aneurysm, who had undergone a previous infra-renal abdominal Y-graft, a staged replacement of remaining segments was performed. A hybrid procedure of open-laparotomy debranching of visceral branches and endovascular stentgraft insertion in the thoracoabdominal aorta was performed first, followed by subsequent direct replacement between the proximal ascending and distal arch using cardiopulmonary bypass. Three months thereafter dissection of enlarged proximal descending aorta occurred, for which we performed an emergent endovascular stentgraft deployment which bridged "elephant trunk" of the arch graft and the previous stentgraft. Consequently total aortic replacement was successfully accomplished without any neurological sequela.
• Kazui, T., Kin, H., Tsuboi, J., Yoshioka, K., Okabayashi, H., & Kawazoe, K. (2008). Perioperative dynamic morphological changes of the aortic annulus during aortic root remodeling with aortic annuloplasty at systolic and diastolic phases. The Journal of heart valve disease, 17(4), 366-70.
  More info

  The study aim was to determine the three-dimensional motion of the semilunar attachment of leaflets (annulus) and the aortic root in annuloaortic ectasia with aortic insufficiency (AI).
• Nakajima, T., Kawazoe, K., Kataoka, T., Kin, H., Kazui, T., Okabayashi, H., & Niinuma, H. (2007). Midterm results of aortic repair using a fabric neomedia and fibrin glue for type A acute aortic dissection. The Annals of thoracic surgery, 83(5), 1615-20.
  More info

  Controversy exists concerning the optimal surgical treatment of acute type A aortic dissection to reduce mortality rate and the need for reoperation. The goal of the present study was to evaluate midterm results of repair using a fabric and fibrin glue for acute type A aortic dissection.
• Izumoto, H., Kawazoe, K., Oka, T., Kazui, T., Kawase, T., & Nasu, M. (2006). Aortic valve repair for aortic regurgitation: intermediate-term results in patients with tricuspid morphology. The Journal of heart valve disease, 15(2), 169-73; discussion 173.
  More info

  Surgical results after aortic valve repair in patients with aortic regurgitation (AR) of tricuspid valve morphology and with no evidence of aortic root disease have not yet been clarified.
• Kazui, T. (2006). An infected internal iliac artery aneurysm causing an arterio-colonic fistula. Chirurgia, 19, 227-9.
• Kazui, T., Doi, H., Suzuki, M., Okamoto, T., Koshima, R., Sugiki, K., & Ohno, T. (2006). Initial clinical experience with the Heartstring. The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai zasshi, 54(10), 424-8.
  More info

  The Heartstring is one of the devices that enable proximal anastomosis without clamping the aorta. We have applied the device not only to low-risk patients with normal aortas but also to high-risk patients with diseased aortas. The purpose of this study was to investigate the initial outcomes of using this device.
• Kazui, T., Izumoto, H., Yoshioka, K., & Kawazoe, K. (2006). Dynamic morphologic changes in the normal aortic annulus during systole and diastole. The Journal of heart valve disease, 15(5), 617-21.
  More info

  The three-dimensional motion of semilunar attachment of the leaflet 'annulus' remains obscure. It has been suggested that the aortic root is distensible and moves during the cardiac cycle. In the present study, the aortic root was evaluated using two dimensions. The aortic root, notably motion of the aortic annulus, was evaluated using multidetector computed tomography (MDCT), and a three-dimensional reconstruction of the aortic annulus was performed.
• Nakajima, T., Kawazoe, K., Izumoto, H., Kataoka, T., & Kazui, T. (2005). Effective use of fibrin glue for acute aortic dissection. The Annals of thoracic surgery, 79(5), 1793-4.
  More info

  The use of gelatin-resorcine-formalin (GRF) glue for reconstruction of the vascular wall in the context of acute aortic dissection has become more common. However, anecdotal evidence suggests that use of the GRF glue results in higher rates of postoperative redissection. We describe an alternative method of reinforcing the dissected aorta with fibrin glue that may avoid this complication. A fabric sheet is presoaked in fibrinogen solution and then placed within the false lumen. Thrombin solution is then applied to the fabric sheet. That results in obliteration of the false lumen and effective reinforcement of the dissected wall.
• Kazui, T. (2004). [A case of metastatic left ventricular tumor causing acute lower limb embolisms]. Jpn. J. Cardiovasc. Surg, 33, 68-71.
• Kazui, T., Izumoto, H., Nasu, M., & Kawazoe, K. (2004). Perioperative changes in dynamic aortic root morphology after Yacoub's root remodeling and concomitant aortic annuloplasty. Interactive cardiovascular and thoracic surgery, 3(3), 465-9.
  More info

  We have performed aortic root remodeling concomitant with aortic annuloplasty (subvalvular circular annuloplasty: it tightens the aortic annulus, using Gore-Tex strip (N.L. Gore and Associates, Arizona, USA)) in patients with AAE and AR. We examined morphologic changes in the aortic root during cardiac cycles, using pre- and post-operative echocardiography. Twelve patients were underwent the procedure. Their grade of AR was 3.2+/-1.0. Five adults with normal aortic roots were studied as controls. The systolic and diastolic radius of each cusp was measured at the annulus, the Valsalva and the STjunction level. The ratio of diastolic radius to systolic radius in the control, pre-operative data and post-operative data was obtained. In the controls, the rate of diameter change during the cardiac cycle was largest at the annulus level (Right coronary cusp (RCC), Left coronary cusp (RCC), Noncoronary cusp (NCC); 1.00+/-0.2, 1.12+/-0.1, 1.23+/-0.2), second largest at Valsalva level (RCC, LCC, NCC; 0.96+/-0.6, 1.07+/-0.2, 0.97+/-0.2), and smallest at the ST junction (RCC, LCC, NCC; 0.95+/-0.4, 1.03+/-0.2, 0.93+/-0.2). Pre-operative data showed that it was largest at the Valsalva level. Post-operative data showed that the rate of change at each level was not significantly different from the control data. All patients were in NYHA class I and the grade of AR was 0.4+/-0.7 at the latest follow-up. Subvalvular circular annuloplasty did not interfere with annulus motion during the cardiac cycle. Aortic root remodeling and concomitant aortic annuloplasty restored near normal cyclic aortic root motion and morphology on the short-term.
• Kazui, T. (2003). [Aortic valve repair with minimal access "J" sternotomy]. The Japanese Journal of Thoracic Surgery, 56, 155-7.
• Kazui, T., Kin, H., Izumoto, H., Nakajima, T., Ishihara, K., & Kawazoe, K. (2003). Combined aortic and mitral valve repair. Asian cardiovascular & thoracic annals, 11(4), 319-22.
  More info

  Six patients, median age 63.3 years (range, 54 to 68 years), underwent concomitant mitral and aortic valve repair from January 2000 to August 2001. Surgical reports and general clinical data were reviewed retrospectively. All patients had degenerative valvular disease, although one patient also had annuloaortic ectasia. There were no surgical complications. The 30 day survival rate was 100%, and the New York Heart Association classification score improved from 2.2 (range, 1 to 2) preoperative, to 1.0 (all patients) postoperatively (p = 0.03) As measured by intraoperative transesophageal echocardiography, the left ventricular end-diastolic diameter decreased from 6.0 cm (range, 5.4 to 6.3 cm) to 4.7 cm (range, 4.0 to 5.2 cm) and the left ventricular end-systolic diameter decreased from 3.7 cm (range, 3.4 to 4.1cm) to 3.1 cm (range, 2.9 to 3.7 cm). No patient developed endocarditis, thromboembolism or hemorrhage. There was no valve related morbidity during a 1 year follow up. Double valve repair is an acceptable alternative to valve replacement in selected patients with some types of valvular disease. Longer term follow up with greater numbers of patients is needed.
• Kazui, T. (2002). [ A case of combined bilateral deep femoral artery aneurysms, abdominal artery aneurysm and multiple aneurysms]. Jpn. J. Vasc. Surg, 11, 657.
• Kazui, T., Koizumi, J., Kataoka, T., Okada, O., Mukaida, M., Kawase, T., Izumoto, H., Nakajima, T., Ishihara, K., & Kawazoe, K. (2002). [Redo coronary artery bypass grafting using the patent left internal thoracic artery graft as an in flow with composite internal thoracic artery Y grafting; report of a case]. Kyobu geka. The Japanese journal of thoracic surgery, 55(10), 891-4.
  More info

  In redo coronary artery bypass grafting (CABG), graft selection and revascularization methods are major problems. We experienced a redo-CABG with occluded previous vein grafts. These grafts were to the circumflex artery and right coronary artery. We conducted operation using cardiopulmonary bypass. We at this operation, chose right internal thoracic artery (RITA) as a conduit and anastomosed it to the side of functioning left internal thoracic artery (LITA) graft, and then diogonal branch, posterolateral branch, and atrioventricular branch were revascularized with the RITA. Post operative course was uneventful. Internal thoracic artery (ITA) is superior to vein graft and other arterial graft as to long term patency. We believe composite Y graft with the use of bilateral ITA can be one of the revascularization strategy in redo CABG.

Presentations

• Kazui, T., Kolimas, A., Ajmal, M., Avila, D., Kotagiri, R., Moynahan, K., & Corban, M. (2022, November). Infective endocarditis of the mitral valve in an immunocompetent patient caused by lactobacillus species. American Heart Association Scientific Sessions. Chicago.
• Kazui, T. (2014, November). Long term valvular outcomes with patients supported with HVAD and HeartMate II LVADS. AHA Scientific Session. Chicago IL United States: American Heart Association.
  More info

  oral presentation
• Kazui, T. (2017, April). HeartMate II inflow cannula angle, migration and inflow cannula mitral alignment over long term support adversely affect on pump thrombosis. Japan Surgical Society 117th Annual Scientific Meeting. Tokyo.
• Kazui, T. (2020, April). The difference of career pathway as a cardiac surgeon between Japan and United States.. The 120th Annual Congress of Japan Surgical Society. Yokohama, Japan: Japan Surgical Society.
• Kazui, T. (2020, March). FEASIBILITY OF THREE-DIMENSIONAL CARDIAC MAGNETIC RESONANCE IMAGING (3D-CMR) FOR PREOPERATIVE PLANNING OF TRANS-CATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. ACC.20 Together With World Congress of Cardiology. Chicago: American College of Cardiology.
• Kazui, T. (2021, June). Mitigating bleeding risk in SARS-CoV-2 infected patients requiring extracorporeal membranous oxygenator support: A focus on fibrinogen. 2021 ASAIO annual conference. Washington, DC/online United States: ASAIO.
• Kazui, T. (2021, June). The outcomes of mobile intensive care unit with double lumen catheter cannulation at referring facility for Veno-venous extracorporeal membrane oxygenation interfacility transfer. ASAIO annual conference. Washington, DC/online United States: ASAIO.
• Kazui, T. (2021, September-October). Pre transcatheter aortic valve replacement 5m walk test score predicts 1-year noncardiac mortality. 47th Western Thoracic Surgical Association Annual Meeting. Phoenix, AZ: Western Thoracic Surgical Association.
• Kazui, T., & Fairbairn, K. (2021, May/). Emergent Left Ventricular Assist Device Pump exchange concomitant with aortic valve closure due to pump thrombosis and aortic insufficiency. The International Society for Heart and Lung Transplantation 41st annual meeting. Toronto: ISHLT.
• Kazui, T., & Hsu, C. (2020, April). The high risk and prohibitive risk transcatheter aortic valve replacement in low risk era. The 120th Annual Congress of Japan Surgical Society. Yokohama, Japan: Japan Surgical Society.
• Kazui, T., Kazui, T., Cosgrove, R. H., Cosgrove, R. H., Hewlett, D. A., Hewlett, D. A., Basken, R. L., Basken, R. L., Smith, R. G., Smith, R. G., Avery, R. J., Avery, R. J., Suryanarayana, P. G., Suryanarayana, P. G., Juneman, E. B., Juneman, E. B., Cook, J. L., Cook, J. L., Lick, S. D., , Lick, S. D., et al. (2017, April). D-dimer as a Prognostic Indicator for Survival or Death in Mechanical Circulatory Support Device Patients. International Society for Heart and Lung Transplantation 37th Annual Meeting and Scientific Sessions. SanDiego: ISHLT.
• Kazui, T., Kazui, T., Lick, S. D., Lick, S. D., Smith, R. G., Smith, R. G., Avery, R. J., Avery, R. J., Suryanarayana, P. G., Suryanarayana, P. G., Juneman, E. B., Juneman, E. B., Cook, J. L., Cook, J. L., Sweitzer, N. K., Sweitzer, N. K., Khalpey, Z. I., & Khalpey, Z. I. (2017, April). Minimally Invasive Off Pump HVAD Placement in Redo PAtients: Is it a Better Approach?. International Society for Heart and Lung Transplantation 37th Annual Meeting and Scientific Sessions. SanDiego: ISHLT.
• Kazui, T., Larsen, B. T., Smith, R. G., Khalpey, Z. I., & Lick, S. D. (2017, April). Native myocardial embolus to donor left anterior descending artery after total artificial heart explant: a cautionary note. International Society for Heart and Lung Transplantation 37 th annual meting and scientific sessions. SanDiego: ISHLT.
• Kazui, T., Larsen, B. T., Smith, R. G., Khalpey, Z. I., & Lick, S. D. (2017, Arpil). Native myocardial embolus to donor left anterior descending artery after total artificial heart explant: a cautionary note. International Society for Heart and Lung Transplantation 37th Annual meeting and scientific sessions. SanDiego: ISHLT.
• Kazui, T., Lick, S. D., Smith, R. G., Avery, R. J., Suryanarayana, P. G., Juneman, E. B., Cook, J. L., Sweitzer, N. K., & Khalpey, Z. I. (2017, April). Minimally Invasive Off-Pump HVAD vs Full Sternotomy On-Pump LVAD Placement: A Better Option?. International Society for Heart and Lung Transplantation 37th Annual meeting and scientific sessions. SanDiego: ISHLT.
• Kazui, T., Suryanarayana, P. G., Singh, S., Smith, R. G., Avery, R. J., Juneman, E. B., Cook, J. L., Sweitzer, N. K., Lick, S. D., & Khalpey, Z. I. (2017, April). A Minimally Invasive Left Ventricular Assist Device Surgical Approach is More Durable at Protecting Right Ventricular Function Than a Full Sternotomy. International Society for Heart and Lung Transplantation 37th Annual meeting and scientific sessions. SanDiego: ISHLT.
• Hsu, C., Malo, J., Mosier, J. M., Natt, B., Hypes, C., Lick, S. D., & Bull, D. A. (2019, May/). Duration and Outcomes of Veno-Venous Extracorporeal Membrane Oxygenation Support in Acute Respiratory Distress Syndrome: Results from ELSO database. American association for thoracic surgery 99th annual meeting. Toronto: American association for thoracic surgery.
• Kazui, T., Lick, S. D., Hsu, C., & Bull, D. A. (2019, January). Does use of bilateral mammary arteries increase short-term risk in diabetic patients? Results from The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 55th STS annual meeting. San Diego: STS.
• Kazui, T. (2016, April). Thromboelastographic Evidence for Reduced Dose Enoxaparin or Fondaparinux Bridge Therapy in Mechanical Circulatory Support Patients with Sub-therapeutic INR. ISHLT 36th annual meeting and Scientific Sessions. Washington, DC: International Society for Heart & Lung Transplantation (ISHLT).
• Kazui, T. (2016, June). Caval Occlusion Improves Performance of Beating Heart Epicardial Radiofrequency Ablation. ISMICS 16th Annual Scientific Meeting. Montreal Quebec, Canada: International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS).
• Kazui, T. (2016, March). Simple and Rliable Bileaflet Foldoplasty in Barlow's Disease: Report of 2 Cases. 2nd annual meeting Heart Valve Conference. New York City, NY: Heart Valve Society.
• Kazui, T. (2015, January). The benefits of learning hTEE as a CV Surgery Fellow. 51st STS annual meeting. San Diego, California: Society of Thoracic Surgeons (STS).
• Kazui, T. (2015, October). The initial experience of off pump biventricular assist device placement in acute biventricular failure. Annual meeting of the Japanese Association for Thoracic Surgery in Kobe, Japan.
• Kazui, T., Day, K., Jokerst, C., & Avery, R. (2015, November). The Total Artificial Heart: Historical Perspectives, Current Applications, Future Directions. Radiological Society of North America. Chicago, IL: Radiological Society of North America.
• Kazui, T., Slivestry, S. C., Keith, A., & Itoh, A. (2015, January). Long-Term Progression of Aortic Insufficiency Is Less in Patients Supported with HVAD LVADs Compared to HeartMate II Patients. 51st STS annual meeting. San Diego CA: Society of Thoracic Surgeons (STS).
• Kazui, T., Tran, P. L., Perovic, V., Mikail, P., Smith, R., Wong, R., Slepian, M., & Khalpey, Z. (2015, February). Case Report: Inaccurate HeartMate II Left Bentricular Assist Device Flow in the Patient with Extensive Ventricles Repair. The American Academy of Cardiovascular Perfusion. San Antonio, Texas: The American Academy of Cardiovascular Perfusion.
• Kazui, T., Tran, P. L., Perovic, V., Mikail, P., Smith, R., Wong, R., Slepian, M., & Khalpey, Z. I. (2015, February). Case report: Inaccurate HeartMatell Left Ventricular Assist Device Flow in the Patient with Extensive Ventricles Repair. The American Academy of Cardiovascular Perfusion. San Antonio, Texas: The American Academy of Cardiovascular Perfusion.
• Kazui, T., Watanabe, Y., Weimar, T., Lee, U., Schuessler, R. B., & Damiano, R. J. (2015, January). The Impact of Prolonged Atrial Fibrillation on Atrial and Ventricular Function in a Porcine Model. 51st STS annual meeting. San Diego, California: Society of Thoracic Surgeons (STS).
• Kazui, T., Zhang, A., Greenberg, J., Keith, A. D., Itoh, A., Ewald, G. A., Damiano, R. J., & Silvestry, S. C. (2015, January). Left Ventricular Assist Device Inflow Position and Pump Migration Adversely Impact LVAD Function. 51st STS annual meeting. San Diego, California: Society of Thoracic Surgeons (STS).
• Kevin, D., C, J., Avery, R. J., Khalpey, Z. I., Oliva, I. B., Kazui, T., & Desai, V. (2015, Novemeber). The Total Artificial Heart: Historical Perspectives, Current Applications, Future Directions. RSNA 101st Scientific Assembly and Annual Meeting. Chicago, Illinois: Radiologic Society of North America.
• Kazui, T. (2014, May). The impact of LVAD program volume and transplant status on cost, quality, and survival in the UHC database 2010-2012. ISHLT. San Diego, CA: ISHLT.
  More info

  oral presentation
• Kazui, T. (2014, November). Left ventricular assist device inflow cannula mitral alignment and pump migration impact LVAD dysfunction over long term support. AHA Scientific Session. Chicago, IL United States: American Heart Association.
  More info

  oral presentation
• Kazui, T. (2013, June). Factors affecting the efficacy of pericardial ablation using a cooled radiofrequency device. 13th ISMICS. Prague, Czech Republic: ISMICS.
  More info

  oral presentation
• Kazui, T. (2013, June). Performance of a Novel Bipolar/Monopolar radiofrequency ablation device on the beating heart in an acute porcine model. 13th ISMICS. Prague, Czech Republic: ISMICS.
  More info

  oral presentation
• Kazui, T. (2013, March). Short-Term and Long-Term Outcomes in Patients with Chronic Obstructive Pulmonary Disease Undergoing Isolated Aortic Valve Replacement for Aortic Stenosis. 62nd Annual Scientific Session and Expo ACC 13J Am Coll Cardiol.
  More info

  doi: 10.1016/S0735-1097(13)61981-6
• Kazui, T. (2013, November). Intra operative and early post-op management. 9th MSC Fellows National Summit. Pleasanton, CA United States: MSC Fellows National Summit.
  More info

  oral presentation
• Kazui, T. (2013, October). Current LVAD therapy for severe heart failure. Annual meeting of the Japanese Association for Thoracic Surgery in Sendai, Japan.
• Kazui, T. (2011, June). Epicardial ablation performance of a novel radiofrequency device on the beating heart in a porcine model. 11th ISMICS. Washington, DC, United States: ISMICS.
  More info

  oral presentation
• Kazui, T. (2011, September). Low-energy electrotherapy significantly reduces the atrial defibrillation threshold in a canine model of atrial fibrillation. Northwestern Cardiovascular Young Investigator's Forum. Chicago, United States: Northwestern Cardiovascular Association.
  More info

  oral presentation
• Kazui, T. (2010, February). Surgical treatment of nonocclusive mesenteric ischemia after cardiovascular surgery. Annual meeting of the Japanese Society for Cardiovascular Surgery.
• Kazui, T. (2009, April). Short term results of atrial fibrillation surgery m;ainly using cut and sew technique. Annual meeting of the Japanese Society for Cardiovascular Surgery.
• Kazui, T. (2007, February). Aortic root morphology and aortic valve functions after aortic annuloplasty with aortic root remodeling. Annual meeting of the Japanese Society for Cardiovascular Surgery.
• Kazui, T. (2007, June). Perioperative dynamic morphologic changes of the aortic annulus in aortic root remodeling with aortic annuloplasty during systole and diastole. Biannual Meeting of the Society for Heart Valve Disease. New York, United States: Society for Heart Valve Disease.
  More info

  oral presentation
• Kazui, T. (2007, May). Aortic root remodeling with subvalvular circular annuloplasty: midterm results. Annual meeting of the Japanese Society of Vascular Surgery.
• Kazui, T. (2006, April). The impact of aortic annuloplasty in the aortic root remodeling. Annual meeting of the Japanese Society for Cardiovascular Surgery.
• Kazui, T. (2005, April). What type of aortic root operation do we choose?: Aortic valve sparing operation or aortic root replacement. Annual meeting of the Japanese Society for Cardiovascular Surgery.
• Kazui, T. (2005, June). Dynamic morphologic changes in the normal aortic annulus during systole and diastole. Biannual Meeting of the Society for Heart Valve Disease. Vancouver, Canada: Society for Heart Valve Disease.
• Kazui, T. (2004, February). Myectyomy and myotomy for HOCM. Annual meeting of the Japanese Society for Cardiovascular Surgery.
• Kazui, T. (2004, October). Effectiveness of subvalvular circular annuloplasty for the aortic root remodeling. Annual meeting of the Japanese Association for Thoracic Surgery.
• Kazui, T. (2003, October). Perioperative changes in dynamic aortic root morphology after Yacoub's root remodeling and concomitant aortic annuloplasty. Annual Joint Meeting of EACTS/ESTS. Vienna, Austria: EACTS/ESTS.
• Kazui, T. (2002, May). Combined aortic and mitral valve repair. Annual Meeting of the Asian Society for Cardiovascular Surgery. Jeju, Korea: Asian Society for Cardiovascular Surgery.
  More info

  oral presentationpeer-reviewed presentation at International Conference
• Kazui, T. (2002, October). Short term result of aortic root remodeling. Annual meeting of the Japanese Association for Thoracic Surgery.

Poster Presentations

• Kazui, T., Hamidi, M., & Janardhanan, R. (2022, March). Apical displacement of bioprosthetic mitral valve resulting in left ventricular outflow tract obstruction, 

   . Heart Valve Society. Miami, FL,.

• Muhammad, A., Kazui, T., Kolimas, A., Kotagiri, R., Avila, D., Moynahan, K. F., Corban, M., Corban, M., Moynahan, K. F., Avila, D., Kolimas, A., Kotagiri, R., Muhammad, A., Kazui, T., Kazui, T., Kotagiri, R., Avila, D., Corban, M., Moynahan, K. F., , Kolimas, A., et al. (2022, November). Infective endocarditis of the mitral valve in an immunocompetent patient caused by lactobacillus species. American Heart Association Scientific Sessions 2022. Chicago: AHA.
• Crabbe, S., Malo, J., Natt, B., Kazui, T., Khalpey, Z. I., Roy-Chaudhury, A., Mosier, J. M., & Hypes, C. (2018, February). Duration of Mechanical Ventilation and Patient Outcomes for Extracorporeal Membrane Oxygenation. SCCM Annual Meeting 2018.
• Crabbe, S., Malo, J., Natt, B., Khalpey, Z. I., Kazui, T., Roy-Chaudhury, A., Mosier, J. M., & Hypes, C. (2018, February). EVALUATION OF THE RESP SCORE FOR SURVIVAL PREDICTION IN VENOVENOUS ECMO. SCCM Annual Meeting.
• Natt, B., Mosier, J. M., Lutrick, K., Hypes, C., Malo, J., Kazui, T., & Cairns, C. B. (2017, Spring). Demographics of severe influenza during the 2016 season: A tertiary care hospital experience. SCCM Annual Congress. Honolulu, HI.
• Kazui, T., Kazui, T., Bull, D. A., Hsu, C., Hsu, C., Lick, S. D., Malo, J., Malo, J., Hypes, C., Mosier, J. M., Mosier, J. M., Natt, B., Natt, B., Natt, B., Mosier, J. M., Hypes, C., Hypes, C., Malo, J., Lick, S. D., , Lick, S. D., et al. (2020, April). Interfacility transfer via a mobile intensive care unit following a double lumen catheter cannulation at the referring facility for veno-venous extracorporeal membrane oxygenation. THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION 2020 Scientific Program. Montreal, Canada: THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION.
• Kazui, T., Hsu, C., Lick, S. D., & Bull, D. A. (2019, October). Venovenous extracorporeal membrane oxygenation and risk factors for adverse outcomes in acute respiratory distress syndrome: Results from the extracorporeal life support organization database. 2nd Annual Scientific Meeting of the Japanese Association for Thoracic Surgery. Kyoto, Japan: Japanese Association for Thoracic Surgery.
• Cosgrove, R., Basken, R., Kazui, T., Smith, R., Finger, J., Lick, S. D., & Khalpey, Z. I. (2017, Oct). A “Goldilocks” experience with various enoxaparin bridge doses reflected by thromboelastogram results in total artificial heart patients. The 2017 ISMCS Conference. Tucson: ISMCS.
• Cosgrove, R., Finger, J., Kazui, T., Smith, R., Basken, R., Lick, S. D., & Khalpey, Z. I. (2017, Oct). Heparin induced thrombocytopenia in left ventricular assist device patients: Therapeutic considerations. The 2017 ISMCS Conference. Tucson: ISMCS.
• Kazui, T., Crabbe, S., Malo, J., Natt, B., Khalpey, Z., Roy-Chaudhury, A., Mosier, J., & Hypes, C. (2017, November). Duration of Mechanical Ventilation and Patient Outcomes for Extracorporeal Membrane Oxygenation. Junior Investigator Poster Forum. Tucson Arizona: College of Medicine - Tucson Founders' Week Event.
• Kazui, T., Crabbe, S., Malo, J., Natt, B., Khalpey, Z., Roy-Chaudhury, A., Mosier, J., & Hypes, C. (2017, November). Evaluation of the RESP Score for Survival Prediction in Venovenous Extracorporeal Membrane Oxygenation. Junior Investigator Poster Forum. Tucson Arizona: College of Medicine - Tucson Founders' Week Event.
• Kazui, T., Kazui, T., Lick, S. D., Lick, S. D., Avery, R., Avery, R., Juneman, E. B., Juneman, E. B., Cook, J., Cook, J., Sweitzer, N. K., Sweitzer, N. K., Khalpey, Z. I., & Khalpey, Z. I. (2017, Oct). Minimally invasive off-pump HVAD vs full sternotomy on-pump LVAD placement: comparison of clinical outcomes. The 2017 ISMCS Conference. Tucson: ISMCS.
• Kazui, T., Lick, S. D., Avery, R., Juneman, E. B., Cook, J., Sweitzer, N. K., & Khalpey, Z. I. (2017, Oct). The effectiveness of minimally invasive off pump HVAD placement in redo patients. The 2017 ISMCS Conference. Tucson: ISMCS.
• Baalachandran, R., Trutter, L., Raz, Y., Mosier, J. M., Kazui, T., & Malo, J. (2016, Spring). Successful Use of Extracorporeal Membrane Oxygenation in a Patient with Pulmonary Coccidioidomycosis-Related Acute Respiratory Distress Syndrome.. American Thoracic Society Annual Meeting. San Francisco, CA.
• Natt, B., Malo, J., Hypes, C., Kazui, T., Basken, R., & Mosier, J. M. (2016, August). Outcomes of Patients with Severe Influenza Treated at the Banner-University Medical Center During the 2015-16 Influenza Season. Options IX for the Control of Influenza. Chicago.
• Natt, B., Malo, J., Hypes, C., Kazui, T., Basken, R., Mosier, J. M., Natt, B., Malo, J., Hypes, C., Kazui, T., Basken, R., & Mosier, J. M. (2016, August/Summer). Outcomes of Patients with Severe Influenza Treated at the Banner-University Medical Center During the 2015-16 Influenza Season. Options IX for the Control of Influenza. Chicago, IL.
• Natt, B., Natt, B., Malo, J., Malo, J., Hypes, C., Hypes, C., Kazui, T., Kazui, T., Basken, R., Basken, R., Mosier, J. M., & Mosier, J. M. (2016, Summer). Outcomes of Patients with Severe Influenza Treated at the Banner-University Medical Center During the 2015-16 Influenza Season. Options IX for the Control of Influenza. Chicago, IL.

Reviews

• Kazui, T., Shanmugasundaram, M., & William, P. (2018. Aortic Stenosis in Older Adults.

Case Studies

• Kazui, T., Niinuma, H., Yamasaki, M., Abe, K., Watanabe, S., & Kawazoe, K. (2012. Septal myectomy and myotomy attenuate left ventricular hyper-contractility in a child with hypertrophic obstructive cardiomyopathy(pp 162-5).
  More info

  Septal hyper-contractility is thought to be the principal cause of significant left ventricular outflow tract obstruction (LVOT) and systolic anterior motion (SAM) of the mitral valve by making the distance between the mitral valve and papillary muscle shorter. A seven-year-old patient with severe hypertrophic obstructive cardiomyopathy underwent direct interventricular septal myectomy/myotomy using the resection/crush method to modify hyper-contractility. The procedure successfully reduced the pressure gradient from 180 mmHg to 7.6 mmHg, and systolic anterior movement of the mitral leaflet disappeared. Mitral regurgitation improved from grade 2 to grade 0. Postoperative echocardiographic vector velocity imaging (VVI) study revealed a reduced twist angle, depicting attenuated ventricular contraction power from a maximum twist 17.9° to 7.9°. Perioperative VVI revealed that interventricular septal myectomy/myotomy is useful, not only in reducing LVOT obstruction, but also in reducing hyper-contractility, which increases the distance from the mitral valve to the papillary muscle and relieves SAM.
• Kazui, T., Yamasaki, M., Abe, K., Watanabe, S., & Kawazoe, K. (2012. Non-obstructive mesenteric ischemia: a potentially lethal complication after cardiovascular surgery: report of two cases(pp 56-60).
  More info

  We report two cases of non-obstructive mesenteric ischemia (NOMI), a rare but potentially lethal complication after cardiovascular surgery, which was successfully managed. In both cases (a 74-year-old chronic hemodialysis patient who underwent emergency aortic valve replacement and coronary artery bypass graft (CABG), and a 74-year-old patient who underwent emergency abdominal aortic aneurysm operation), NOMI occurred early postoperatively (on day 8 and 22, respectively). They suffered from severe abdominal pain, confusion, and metabolic acidosis. Contrast-enhanced multi-detector CT (MDCT) scan and subsequent selective mesenteric angiography revealed characteristic signs of NOMI, for which selective papaverine infusion through the angiography catheter was performed. It was effective in both cases to halt progressive bowel ischemia and bided our time to perform a hemicolectomy of the necrotic segment. Contrast-enhanced MDCT scan and subsequent selective angiography are vital for diagnosis. If the condition does not improve after selective papaverine infusion, exploratory laparotomy and resection of necrotic intestinal segment should be performed immediately.
• Kazui, T., Mitsunaga, Y., Nakajima, T., & Okabayashi, H. (2010. Bentall operation with saphenous vein graft for a Takayasu's aortitis patient(pp 373-5).
  More info

  Takayasu's aortitis patients present a variety of symptoms, including angina pectoris, aortic valve regurgitation, and aortic branch stenosis. The case described in this paper primarily presented with angina pectoris. Close investigation revealed a left coronary artery ostium lesion, an aortic root aneurysm, and a mild aortic regurgitation. The patient underwent a modified Bentall operation with saphenous vein graft (SVG) replacement of the left main trunk. The postoperative course was uneventful, and the patient received oral steroid therapy. SVG is a useful option in treating aortic root aneurysm with an ostium lesion.
• Kazui, T., Mitsunaga, Y., Fukuhiro, Y., Nakajima, T., & Okabayashi, H. (2008. Aortic root reimplantation using a Valsalva graft for postoperative pseudoaneurysm after acute aortic dissection(pp 339-42).
  More info

  We report a reoperative case in which a Valsalva graft was utilized on a 64-year-old woman who had previously undergone emergency repair of a DeBakey type I acute aortic dissection. On follow-up computed tomography (CT), she was found to have pseudoaneurysms of both proximal and distal anastomoses. We performed valve-sparing aortic root replacement (VSRR) with the reimplantation technique and total arch replacement, since we felt that a graft with pseudosinuses helps to prevent torsion of the coronary arteries. The postoperative course was uneventful, and postoperative echocardiography revealed no significant aortic valve regurgitation. The pathology results raised the hypothesis that pseudoaneurysm formation might have been related to the use of gelatin-resorcinol-formaldehyde (GRF) glue at the time of the initial intervention.
• Nakai, K., Kazui, T., Okabayashi, H., Hayashi, R., Fukushima, A., & Suwabe, A. (2008. [Development of three-dimensional analysis of current density distribution by 64-ch magentocardiography and clinical application](pp 1118-24).
  More info

  Magnetocardiography (MCG) using a SQUID sensor is characterized by three dimensional cardiac electrical phenomena from magnetic fields, because it is hard to be affected by organ constitution of lungs and torso configuration. We have developed three-dimensional (3D) electric current density distribution analysis by a spatial filter method. At this symposium, we report clinical utility of 64-channel (64-ch) MCG. Subjects consisted of 20 normal volunteers, 10 cases with old myocardial infarction, 13 cases with atrial fibrillation (AFIB) who received surgical pulmonary (PV) isolation, and representative case with fetus premature ventricular complex (PVC). We recorded 10-min MCG data of magnetic field composition (a Bz ingredient) which was perpendicular to body surface in a magnetism shield, using 64-ch SQUID sensors (17.5 x 17.5 cm) built-in in MCG instrumentation(sampling; 500ms, total frequency characteristic; 0.1-200 Hz). We conducted 3D heart outline from electric current density calculated by magnetic field distribution. We also generated 3D functional images of the RT (activation recovery time) dispersion and spatial spectral distribution of a fibrillation wave. Increased fluctuation on RT dispersion map corresponded with space location of myocardial infarction. The mean frequency of 3D spectral map in persistent AFIB showed a higher value than that with restored a sinus rhythm (7.7 +/- 0.5 Hz vs. 6.5 +/- 0.7 Hz). We also demonstrated a fetus PVC. We concluded that 64-ch MCG can evaluate 3D spatial location of myocardial injury, 3D spectral map and characteristic frequency, and fetus arrhythmia. In future, further technical development in the fields of MCG measurement would be necessary for avoiding the used of unshielded room or liquid He.
• Okamoto, T., Doi, H., Kazui, T., Suzuki, M., Koshima, R., Yamashita, T., Sugiki, K., & Ohno, T. (2006. Aortic valve myxoma mimicking vegetation: report of a case(pp 927-9).
  More info

  We report a case of cardiac myxoma of the aortic valve. To our knowledge, this represents only the seventh such case ever documented. A 61-year-old woman underwent an echocardiography to screen for hypertensive-diabetic cardiac complications, which showed a mass on her aortic valve. Although she had not experienced a fever, the mass closely resembled a vegetation, resulting in an initial diagnosis of infective endocarditis. We extirpated the mass and repaired the aortic valve with the patient under cardiopulmonary bypass. The postoperative course was uneventful. Histological examination confirmed that the mass was a myxoma.
• Kazui, T., Nagumo, T., Izumoto, H., Komoda, K., Tanita, T., & Kawazoe, K. (2004. [Surgically repaired bilateral giant bullae after long-time follow-up; report of a case](pp 253-7).
  More info

  A 44-year-old male was admitted to our hospital owing to severe dyspnea of sudden onset. Chest X-ray disclosed bilateral giant bullae. His pulmonary function was severely depressed. VC (%) was 2.61 l (66.3%) and FEV1% (%) was 1.47 l (64.5%). Indication of surgical repair of giant bullae are; space occupying lesion more than 25-50% in 1 thorax, progressive dyspnea, enlargement over time irrespective of symptoms, and expectation that re-expand the normal lung. He was conducted two-staged bullectomy using video-assisted thoracoscopic surgery (VATS) with small incisions. First operation was performed to left lung. Pulmonary function improved. VC (%) increased 3.02 l (76.8%) and FEV1% (%) 2.36 l (76.6%). After second operation, which was performed to right lung, VC (%) was 2.40 l (60.5%) and FEV1% (%) was 2.21 l (92.1%). Hugh-Jones grade improved class IV to class I. Postoperative course was uneventful and he was discharged 15 days after second operation. Two-staged bullectomy was appropriate in this case, because he might have suffered from re-expansion pulmonary edema after first surgery. The extent of recovery of pulmonary function was unpredictable. And performing right lung bullectomy just after the left bullectomy may be dangerous, because the patient have to receive anesthesia with his resected left lung. There is some possibility that patient who has bilateral giant bullae shows severe dyspnea during the progress, care should be taken to conduct operation as soon as possible.

Others

• Reddy, S., Reddy, S., Lotun, K., Lotun, K., Shetty, R., Shetty, R., Lee, K. S., Lee, K. S., Kazui, T., & Kazui, T. (2017, October). Successful Treatment of Staphylococcus Aureus 28 X 11 mm Mycotic Aneurysm of the Proximal Left Anterior Descending Artery with Endovascular Coiling in High Risk Surgical Patient.. TCT 2017.
• Reddy, S., Reddy, S., Lotun, K., Lotun, K., Shetty, R., Shetty, R., Lee, K. S., Lee, K. S., Kazui, T., & Kazui, T. (2017, October). Transcutaneous Aortic Valve Replacement Within a Previously Placed Surgical and Transcutaneous Prosthetic Valves Under Peripheral Extracorporeal Membrane Oxygenation Support (TandemLife) Hemodynamic Support in a High Risk Patient.. TCT 2017.
• Kazui, T., Doi, H., Suzuki, M., Okamoto, T., Koshima, R., Sugiki, K., & Ohno, T. (2009). [Surgical treatment for infective endocarditis]. Kyobu geka. The Japanese journal of thoracic surgery.
  More info

  Surgery for infective endocarditis (IE) is technically demanding, especially the one for active IE.
• Kazui, T., Tsuboi, J., Izumoto, H., Nakajima, T., Ishihara, K., & Kawazoe, K. (2007). Aortic root remodeling with aortic annuloplasty: mid-term results. Circulation journal : official journal of the Japanese Circulation Society.
  More info

  A retrospective study was performed to determine the appropriateness of aortic root remodeling with aortic annuloplasty (m-Yacoub operation).
• Kazui, T., & Kawazoe, K. (2004). [Acute mitral valve insufficiency caused by chordae rupture]. Kyobu geka. The Japanese journal of thoracic surgery.
  More info

  The common causes of mitral valve chordae rupture are myxomatous valve disease, infective endocarditis. Acute mitral valve insufficiency from chordae rupture, severe clinical symptoms such as dyspnea and shock are observed. Diagnosis is made with clinical symptoms, chest X-ray and echocardiography. Echocardiography is very useful to evaluate the exact lesions. First, inotropic agents, dilators and intraaortic balloon pumping (IABP) are used to stabilize hemodynamic status. Once hemodynamic status becomes unstable in spite of such therapy, surgical correction of mitral regurgitation (MR) is considered. Mitral valve repair should be the first choice of surgical repair, because it preserves left ventricular function, avoids anti-coagulation therapy. Quadrangular resection and suture, annuloplasty and artificial chordae are reliable surgical techniques. If mitral valve repair is difficult, mitral valve replacement is another option. From 1994 to 2002, there were 12 patients who underwent emergency mitral valve surgery because of chordae rupture. There were 7 men and 5 women with mean age of 52.7+/-14.3 years old. Nine of them received mitral valve repair. Two patients were infective endocarditis. Preoperative MR grade was 4.0+/-0.0. Postoperative MR grade was 0.2+/-0.2. Mean follow-up period was 3.8 years. There were no cardiac events and reoperations. Repair technique is quite reliable even in patients with multiple lesions, and the surgical results were almost same as single lesion patients. Repair technique should be the first choice to treat acute MR caused by chordae rupture.